Tranexamic acid

Synthetic derivative of the amino acid lysine

Commonly marketed in tablet form as Lysteda and in IV form as Cyklokapron in the U.S. and as Transamin,Transcam in Asia, and Espercil in South America

Antifibrinolytic that competitively inhibits the activation of plasminogen to plasmin, a molecule responsible for the degradation of fibrin

Fibrin is the basic framework for the formation of a blood clot in hemostasis

Has roughly 8 times the antifibrinolytic activity of an older analogue, ε-aminocaproic acid